US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sinovac Biotech

6.47

+0.0000

Volume:- -

Turnover:- -

Market Cap:642.44M

PE:6.66

High:6.47

Open:6.47

Low:6.47

Close:6.47

Loading ...

Overview Company News Filings

Granite Publishes Annual Sustainability Report

Sinovac Biotech announces $55.00 per share special dividend

BRIEF-Sinovac Biotech Announces Special Dividend Of $55 Per Common Share

Sinovac Biotech Ltd - Announces Special Dividend of $55 per Common Share

THOMSON REUTERS

Sinovac Announces Record and Distribution Dates for Special Cash Dividend

THOMSON REUTERS

Press Release: SINOVAC Announces Record and Distribution Dates for Special Cash Dividend

Sinovac Biotech issues shareholder letter regarding Vivo Capital claims

BRIEF-Sinovac Biotech Board Issues Letter To Shareholders Against Vivo Capital Claims

Sinovac Biotech Ltd - Board Issues Letter to Shareholders Against Vivo Capital Claims

THOMSON REUTERS

SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital

SINOVAC Management Statement Regarding Auditor Resignation

Sinovac Biotech Faces Audit Challenges Amid Board Legitimacy Issues

Heng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per Share

THOMSON REUTERS

Sinovac Biotech to declare $55.00 per share special cash dividend

Press Release: SINOVAC Announces Decision to Declare Cash Dividend

BRIEF-Sinovac Announces New Board Member And Chairman Of The Audit Committee

SINOVAC Announces New Board Member and Chairman of the Audit Committee

Heng Ren ‘demands’ Sinovac Biotech distribute $8.9B in cash to shareholders

BRIEF-Heng Ren Partners Says Sinovac Should Distribute $8.9 Bln In Cash To Shareholders

Heng Ren Partners in Letter Says Sinovac Should Distribute $8.9 Bln in Cash to Shareholders

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SVA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVA\",,,,,undefined,":{"symbol":"SVA","market":"US","secType":"STK","nameCN":"Sinovac Biotech","latestPrice":6.47,"timestamp":1746216000000,"preClose":6.47,"halted":3,"volume":0,"delay":0,"floatShares":59508401,"shares":99294743,"eps":0.971025,"marketStatus":"Halted","change":0,"latestTime":"05-02 16:11:42 EDT","open":6.47,"high":6.47,"low":6.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.971025,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746230400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1102482000000,"exchange":"NASDAQ","adjPreClose":6.47,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVA\",,,,,undefined,":{"symbol":"SVA","floatShares":59508401,"roa":"11.46%","roe":"25.15%","lyrEps":1.055174,"shares":99294743,"dividePrice":0,"high":6.47,"amplitude":0,"preClose":6.47,"low":6.47,"week52Low":6.47,"pbRate":"0.86","week52High":6.47,"institutionHeld":0.2584,"latestPrice":6.47,"eps":0.971025,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.971025,"open":6.47,"prevYearClose":6.47,"prevWeekClose":6.47,"prevMonthClose":6.47,"prevQuarterClose":6.47,"fiveDayClose":6.47,"twentyDayClose":6.47,"sixtyDayClose":6.47},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SVA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531605557","title":"Granite Publishes Annual Sustainability Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2531605557","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531605557?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:30","pubTimestamp":1746016200,"startTime":"0","endTime":"0","summary":"WATSONVILLE, Calif., April 30, 2025----On Wednesday, April 30, Granite  published its 2024 Sustainability Report, highlighting the company’s efforts to create enduring value through social responsibility, environmental stewardship, and dependable governance. \"Our mission as a business is to provide infrastructure solutions that support more prosperous and resilient communities,\" said Granite President and Chief Executive Officer Kyle Larkin. \"Sustainability is central to this mission. Our teams embrace sustainability as a core value and recognize that our leadership in sustainability supports the successful execution of our business strategies and drives value creation.\". \"In this report, we share Granite’s refreshed Sustainability Strategic Plan, which centers on leveraging sustainability as a competitive advantage,\" explained Sustainability Director Raven Adams. \"The theme of this report—Sustainability Value Add—reflects our focus on creating value for all our stakeholders by advanci","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/granite-publishes-annual-sustainability-report-123000624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4129","NAPA","GVA","SVA","BK4169","BK4139"],"gpt_icon":0},{"id":"2531086868","title":"Sinovac Biotech announces $55.00 per share special dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2531086868","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531086868?lang=en_us&edition=fundamental","pubTime":"2025-04-30 17:36","pubTimestamp":1746005762,"startTime":"0","endTime":"0","summary":"Sinovac Biotech (SVA) announced that a special dividend of $55.00 per common share, as previously announced on April 1, will be paid in cash to val...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sinovac-biotech-announces-55-00-per-share-special-dividend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sinovac-biotech-announces-55-00-per-share-special-dividend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2531862771","title":"BRIEF-Sinovac Biotech Announces Special Dividend Of $55 Per Common Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2531862771","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531862771?lang=en_us&edition=fundamental","pubTime":"2025-04-30 14:03","pubTimestamp":1745992980,"startTime":"0","endTime":"0","summary":"BRIEF-Sinovac Biotech Announces Special Dividend Of $55 Per Common ShareApril 30 (Reuters) - Sinovac Biotech Ltd SVA.O:SINOVAC ANNOUNCES RECORD AND DISTRIBUTION DATES FOR SPECIAL CASH DIVIDENDSINOVAC ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA7YNBT2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2531779176","title":"Sinovac Biotech Ltd - Announces Special Dividend of $55 per Common Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2531779176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531779176?lang=en_us&edition=fundamental","pubTime":"2025-04-30 14:00","pubTimestamp":1745992800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA7YNBT2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2531077968","title":"Sinovac Announces Record and Distribution Dates for Special Cash Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2531077968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531077968?lang=en_us&edition=fundamental","pubTime":"2025-04-30 14:00","pubTimestamp":1745992800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA7YNBT2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2531718587","title":"Press Release: SINOVAC Announces Record and Distribution Dates for Special Cash Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2531718587","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531718587?lang=en_us&edition=fundamental","pubTime":"2025-04-30 14:00","pubTimestamp":1745992800,"startTime":"0","endTime":"0","summary":"Sinovac Biotech Ltd.  , a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, as previously announced on April 1, 2025, will be paid in cash to valid holders of SINOVAC's common shares as of the close of business on May 23, 2025, ET. Such cash dividend is expected to be paid on or about July 9, 2025.SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71  infected hand-foot-mouth disease , hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc.SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","SVA","BK4139","R"],"gpt_icon":0},{"id":"2531209523","title":"Sinovac Biotech issues shareholder letter regarding Vivo Capital claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2531209523","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531209523?lang=en_us&edition=fundamental","pubTime":"2025-04-29 17:30","pubTimestamp":1745919053,"startTime":"0","endTime":"0","summary":"Sinovac Biotech (SVA) announced that its board of directors issued a public letter to shareholders in response to “hostile actions and false claims...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sinovac-biotech-issues-shareholder-letter-regarding-vivo-capital-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sinovac-biotech-issues-shareholder-letter-regarding-vivo-capital-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2531929227","title":"BRIEF-Sinovac Biotech Board Issues Letter To Shareholders Against Vivo Capital Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2531929227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531929227?lang=en_us&edition=fundamental","pubTime":"2025-04-29 15:31","pubTimestamp":1745911881,"startTime":"0","endTime":"0","summary":"BRIEF-Sinovac Biotech Board Issues Letter To Shareholders Against Vivo Capital ClaimsApril 29 (Reuters) - Sinovac Biotech Ltd SVA.O:SINOVAC BIOTECH LTD - BOARD ISSUES LETTER TO SHAREHOLDERS AGAINST VI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R62J6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2531227307","title":"Sinovac Biotech Ltd - Board Issues Letter to Shareholders Against Vivo Capital Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2531227307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531227307?lang=en_us&edition=fundamental","pubTime":"2025-04-29 15:29","pubTimestamp":1745911771,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R62J6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2531278711","title":"SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2531278711","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531278711?lang=en_us&edition=fundamental","pubTime":"2025-04-29 15:29","pubTimestamp":1745911740,"startTime":"0","endTime":"0","summary":"BEIJING, April 29, 2025----Sinovac Biotech Ltd.  , a leading provider of biopharmaceutical products in China, today announced that its board of directors  issued a public letter to shareholders in response to hostile actions and false claims by Vivo Capital and certain other parties  against the legitimate and lawful actions of the Board.Events leading up to this moment and precipitated by the Vivo group have followed a lengthy and complex chronology, which are summarized in the Addendum to this letter.As you also know, on February 28, 2025, we announced that the rightfully elected Board was reconstituted and is actively governing the Company. This followed a judgment on January 16, 2025  and an order issued on February 5, 2025  by the Judicial Committee of the Privy Council  – the final court of appeal for UK overseas territories and the Crown dependencies which was made up of five UK Supreme Court justices – which han","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sinovac-board-issues-letter-shareholders-072900061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ","NVIW.SI","NQmain","TSYW.SI","USJW.SI","SQQQ","SVA","BK4139","QID","MNQmain","USAW.SI",".IXIC","QLD","PSQ"],"gpt_icon":1},{"id":"2529156213","title":"SINOVAC Management Statement Regarding Auditor Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2529156213","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529156213?lang=en_us&edition=fundamental","pubTime":"2025-04-22 12:06","pubTimestamp":1745294760,"startTime":"0","endTime":"0","summary":"Beijing, April 22, 2025  -- To the Shareholders of Sinovac Biotech Ltd. and Other Stakeholders:. The management of Sinovac Biotech Ltd.  recently received notice of its external auditor’s decision to resign from its engagement for the Company’s year-end audit for the fiscal year 2024.In fact, it was under the leadership of the former board that SINOVAC achieved tremendous growth, expanded into multiple international markets, and significantly increased both revenue and shareholder value. The management team supports the distribution of cash dividends to shareholders, which would not have been possible without the initiatives and achievements of the former board. Any attempt to unravel or reverse corporate actions taken by the former board would not only create operational chaos and legal uncertainty but would also undermine the C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sinovac-management-statement-regarding-auditor-040600812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2529208358","title":"Sinovac Biotech Faces Audit Challenges Amid Board Legitimacy Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2529208358","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529208358?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:28","pubTimestamp":1745267295,"startTime":"0","endTime":"0","summary":"Sinovac Biotech ( ($SVA) ) just unveiled an update. On April 15, 2025, Sinovac Biotech Ltd. announced that Grant Thornton Zhitong Certified Public ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sinovac-biotech-faces-audit-challenges-amid-board-legitimacy-issues?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sinovac-biotech-faces-audit-challenges-amid-board-legitimacy-issues?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2526054571","title":"Heng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2526054571","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526054571?lang=en_us&edition=fundamental","pubTime":"2025-04-11 03:44","pubTimestamp":1744314253,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUA4DWHY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2524195508","title":"Sinovac Biotech to declare $55.00 per share special cash dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2524195508","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524195508?lang=en_us&edition=fundamental","pubTime":"2025-04-01 17:50","pubTimestamp":1743501011,"startTime":"0","endTime":"0","summary":"Sinovac Biotech (SVA) announced that the company’s board of directors has decided to declare a special cash dividend of $55.00 per common share. Th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sinovac-biotech-to-declare-55-00-per-share-special-cash-dividend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sinovac-biotech-to-declare-55-00-per-share-special-cash-dividend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2524550134","title":"Press Release: SINOVAC Announces Decision to Declare Cash Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2524550134","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524550134?lang=en_us&edition=fundamental","pubTime":"2025-04-01 12:48","pubTimestamp":1743482880,"startTime":"0","endTime":"0","summary":"Sinovac Biotech Ltd.  , a leading provider of biopharmaceutical products in China, today announced that the Company's board of directors  has decided to declare a special cash dividend of US$55.00 per common share . The Board expects to fund the Dividend from available cash resources of the Company and its subsidiaries, including prior distributions from Sinovac Life Sciences Co., Ltd. and other operating subsidiaries of the Company to Sinovac Biotech  Limited. The Dividend is intended to provide SINOVAC shareholders with their appropriate share of these prior distributions from the Company's subsidiaries. Going forward, the Board also intends for SINOVAC shareholders to receive pro-rata distributions in due course with any distributions made to stakeholders of operating subsidiaries. The Board will work with the Company's management to update the holders of its common shares on the expected record and payment dates for the Dividend as soon as practicable.SINOVAC's product portfolio in","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","R","BK4022","SVA","BK4232"],"gpt_icon":0},{"id":"2522157876","title":"BRIEF-Sinovac Announces New Board Member And Chairman Of The Audit Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2522157876","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522157876?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:53","pubTimestamp":1743162801,"startTime":"0","endTime":"0","summary":"BRIEF-Sinovac Announces New Board Member And Chairman Of The Audit CommitteeMarch 28 (Reuters) - Sinovac Biotech Ltd SVA.O:SINOVAC ANNOUNCES NEW BOARD MEMBER AND CHAIRMAN OF THE AUDIT COMMITTEESource text: ID:nBw7VSHb1aFurther company coverage: SVA.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA1RQSXP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2522522994","title":"SINOVAC Announces New Board Member and Chairman of the Audit Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2522522994","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522522994?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:00","pubTimestamp":1743159600,"startTime":"0","endTime":"0","summary":"BEIJING, March 28, 2025----Sinovac Biotech Ltd.  , a leading provider of biopharmaceutical products in China, today announced that its board of directors  has appointed Sven H. Borho, CFA, as director to the Board to fill in a vacancy created by a recent resignation. As a qualified audit committee financial expert under Nasdaq Rule 5605, Mr. Borho has also been elected as the Chair of the Audit Committee of the Board.Mr. Borho is a founder and Managing Partner of OrbiMed and has over 30 years of experience investing in the healthcare sector. OrbiMed is a leading healthcare investment firm with approximately $17 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds and royalty/credit funds. OrbiMed funds have been shareholders of SINOVAC since 2013 and currently hold over 2.7 million shares.SINOVAC continually dedicates itself to new vac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sinovac-announces-board-member-chairman-110000969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2521231764","title":"Heng Ren ‘demands’ Sinovac Biotech distribute $8.9B in cash to shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2521231764","media":"TipRanks","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521231764?lang=en_us&edition=fundamental","pubTime":"2025-03-21 23:15","pubTimestamp":1742570108,"startTime":"0","endTime":"0","summary":"Sinovac Biotech  shareholder Heng Ren Partners, LLC funds sent an open letter to Sinovac’s shareholders outlining the significant and decisive action that Sinovac’s Board of Directors must take to create liquidity and release cash to shareholders. Specifically, Heng Ren demands that Sinovac’s Board of Directors announce a distribution of $8.9B in cash to its shareholders and cause the resumption of trading of the company’s shares. “After announcing a plan to distribute cash to shareholders, the Company must take all action necessary to cause the resumption of trading of Sinovac’s shares on NASDAQ. The Board must immediately take and disclose all steps that it is taking to make this happen. The Board must inform shareholders of a clear timeline as to when the trading of Sinovac’s shares will resume on NASDAQ. The Board must prevent any trading, by Company management or otherwise, of Sinovac’s shares until full disclosure is made of the Company’s financial condition and other material in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/heng-ren-demands-sinovac-biotech-151508853.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heng-ren-demands-sinovac-biotech-151508853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2521498813","title":"BRIEF-Heng Ren Partners Says Sinovac Should Distribute $8.9 Bln In Cash To Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2521498813","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521498813?lang=en_us&edition=fundamental","pubTime":"2025-03-21 02:39","pubTimestamp":1742495981,"startTime":"0","endTime":"0","summary":"BRIEF-Heng Ren Partners Says Sinovac Should Distribute $8.9 Bln In Cash To ShareholdersMarch 20 (Reuters) - Heng Ren Partners:SINOVAC MUST TAKE ACTIONS TO DISTRIBUTE CASH TO SHAREHOLDERSIN LETTER SAYS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nFWN3Q314E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2520630304","title":"Heng Ren Partners in Letter Says Sinovac Should Distribute $8.9 Bln in Cash to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2520630304","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520630304?lang=en_us&edition=fundamental","pubTime":"2025-03-20 23:09","pubTimestamp":1742483386,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nFWN3Q314E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVA"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SVA\",params:#limit:5,,,undefined,":[{"date":"2025-05-23","symbol":"SVA","amount":55,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-23","defaultRemindTime":1748007000000,"name":"科兴生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-09","payableDate":"2025-05-23","currency":"USD","dateTimestamp":1747972800000,"payDate":"2025-07-09"},{"market":"US","date":"2022-04-29","symbol":"SVA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1651204800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-12-31","symbol":"SVA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1640926800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-09-17","symbol":"SVA","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1631851200000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2021-06-29","symbol":"SVA","fiscalQuarterEnding":"2021/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1624939200000,"reportTimeType":"","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SVA\",market:\"US\",,,undefined,":[{"executeDate":"2025-05-23","recordDate":"2025-05-23","paymentDate":"2025-07-09","value":55,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SVA","date":"2021-09-21","current":5.82081,"percent":0.24257,"low":-100.201212,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"high":42.074882,"avg":0.136365,"sd":42.133061,"marketCap":642436987},"quantilePoints":[{"date":"2020-05-08","current":14.24256,"twenty":-59.560853,"median":25.571939,"eighty":133.776731,"marketCap":639903982},{"date":"2020-05-15","current":14.24256,"twenty":-59.560853,"median":25.47951,"eighty":133.776731,"marketCap":639903982},{"date":"2020-05-22","current":14.24256,"twenty":-59.560853,"median":25.419975,"eighty":133.776731,"marketCap":639903982},{"date":"2020-05-29","current":14.24256,"twenty":-59.560853,"median":25.417891,"eighty":133.776731,"marketCap":639903982},{"date":"2020-06-05","current":14.24256,"twenty":-59.560853,"median":25.356272,"eighty":133.776731,"marketCap":639903982},{"date":"2020-06-12","current":14.24256,"twenty":-59.560853,"median":25.202224,"eighty":133.776731,"marketCap":639903982},{"date":"2020-06-19","current":14.24256,"twenty":-59.560853,"median":25.078985,"eighty":133.776731,"marketCap":639903982},{"date":"2020-06-26","current":14.24256,"twenty":-59.560853,"median":24.986557,"eighty":133.776731,"marketCap":639903982},{"date":"2020-07-02","current":17.165727,"twenty":-59.560853,"median":24.940342,"eighty":133.776731,"marketCap":639903982},{"date":"2020-07-10","current":17.165727,"twenty":-59.560853,"median":24.863319,"eighty":133.776731,"marketCap":639903982},{"date":"2020-07-17","current":17.165727,"twenty":-59.560853,"median":24.709271,"eighty":133.776731,"marketCap":639903982},{"date":"2020-07-24","current":17.165727,"twenty":-59.560853,"median":24.647652,"eighty":133.776731,"marketCap":639903982},{"date":"2020-07-31","current":17.165727,"twenty":-59.560853,"median":24.616842,"eighty":133.776731,"marketCap":639903982},{"date":"2020-08-07","current":17.165727,"twenty":-59.560853,"median":24.555223,"eighty":133.776731,"marketCap":639903982},{"date":"2020-08-14","current":17.165727,"twenty":-59.560853,"median":24.431985,"eighty":132.906863,"marketCap":639903982},{"date":"2020-08-21","current":17.165727,"twenty":-59.560853,"median":24.370365,"eighty":42.074882,"marketCap":639903982},{"date":"2020-08-28","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-04","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-11","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-18","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-25","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":39.649553,"marketCap":639903982},{"date":"2020-10-02","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-09","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-16","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-23","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-30","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-06","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-13","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-20","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-27","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-04","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-11","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-18","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-24","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-31","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2021-01-08","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-01-15","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-01-22","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-01-29","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-05","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-12","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-19","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-26","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-05","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-12","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-19","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-26","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-01","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-09","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-16","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-23","current":5.79786,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-30","current":5.82081,"twenty":-61.894113,"median":24.171596,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-07","current":5.82081,"twenty":-61.894113,"median":24.081398,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-14","current":5.82081,"twenty":-61.894113,"median":23.985687,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-21","current":5.82081,"twenty":-61.894113,"median":23.781276,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-28","current":5.82081,"twenty":-61.894113,"median":23.705864,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-04","current":5.82081,"twenty":-61.894113,"median":23.662388,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-11","current":5.82081,"twenty":-61.894113,"median":23.535556,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-18","current":5.82081,"twenty":-61.894113,"median":23.44385,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-25","current":5.82081,"twenty":-62.119913,"median":23.213593,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-02","current":5.82081,"twenty":-62.119913,"median":22.996932,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-09","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-16","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-23","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-30","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-06","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-13","current":5.82081,"twenty":-61.894113,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-20","current":5.82081,"twenty":-61.894113,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-27","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-03","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-10","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-17","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-24","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-01","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-08","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-15","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-22","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-29","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-11-05","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-11-09","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987}],"updateTime":1746216326412}}}